Medolife Rx Presents Its Venom-To-Drug Development Projects at an International Conference Held in the Dominican Republic

January 11, 2022

Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st

February 19, 2024
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

February 15, 2024
Biotricity Advances Towards Breakeven Milestone – Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024

February 14, 2024
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider

February 14, 2024